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Editorial
The Common Pursuits of The American Journal of
Pathology and Its Readership
As Editor-in-Chief I don’t often get the opportunity to
address my fellow scientists unless it is in the form of a
decision letter. It is easy to think of contributing to aca-
demic journals as engaging in a one-way process. The
author submits a manuscript, which is reviewed, hope-
fully accepted, and then published for critical public ex-
amination by the readership. However, I invite all of us to
remember that journals were originally founded in corre-
spondence. At its heart, this is what scientific publishing
remains: an exchange of ideas and data, a means for our
community to reach out to one another intellectually, a
dynamic relationship. In publishing, we so often talk
about the “reader” and the “author,” perhaps forgetting
that they are often one and the same, contributors to the
scientific process of mutual discovery. In this spirit of
fellowship, I want to share with you selected highlights of
the common pursuits in which we in the editorial office
of The American Journal of Pathology are engaged with
you our colleagues.
The AJP continues to demonstrate its strength in re-
porting the best research in the field of investigative
pathobiology. The most recent journal impact factors
were released by Thomson ISI last summer, with the AJP
earning an impact factor of 6.441 for 2004.1 With this
result the AJP retains its position as the number one-
ranked journal in general pathology; however, it remains
our goal to build on this standing, and continue to expand
our reach and therefore the impact of your work. Impact
factor is but one measure of a journal’s influence in the
field, just as “pathology” could be considered an arbitrary
designation for what is simply the investigation of biolog-
ical disease mechanisms, whether in the guise of immu-
nological, physiological, molecular, or cellular ap-
proaches. Although we appreciate the visibility that these
numbers provide us, we do not regard this as a true and
complete representation of the value of this literature and
thus are resolved to increase the AJP’s impact in various
ways.
To that end, I am pleased that the distinguished ex-
perimentalist Dr. Peter Ward has joined our team as
Special Associate Editor. Dr. Ward has long been a
prominent and well-respected member of the scientific
community, and we are excited that he will be contribut-
ing his energies to the evolution of the AJP. Dr. Ward’s
first undertaking is the development of an exciting new
series of Biological Perspectives for the AJP. These fo-
cused review articles will provide state-of-the-art per-
spectives and mechanistic figures summarizing basic
science advances and translational research to offer a
better understanding of biological processes and more
effective therapeutic interventions in human disease.
Look for the first article in this series to appear in Spring
2006.
In 2004 we announced the appointment of a new Sci-
entific Editor. Many of you who have published with the
AJP in the past year may have had the good fortune of
working with Dr. Audra Cox. I hope you have found her a
valuable resource in assisting you to refine and polish
your abstracts and articles.
Perhaps you have seen research from the AJP publi-
cized in various news outlets. In April we began an ex-
panded media release program to highlight exciting
studies published in the AJP. Each month we select one
or two articles that may be of special interest to the
public. Recent topics covered in these media releases
have included tumor profiling, arthritis, and Alzheimer’s
disease. News stories featuring these articles have ap-
peared online and in print in the lay press of the United
States and abroad. If you receive e-mail announcements
from the AJP (which I encourage each of you to do, by
signing up for free content alerts from the website), these
monthly press releases are delivered directly to your
e-mail inbox. Look for this month’s release spotlighting
H5N1 influenza research, a timely topic because of the
current bird flu outbreak.
Furthermore, we continue to seek ways to make the
review and publication of your work more efficient. Our
average turnaround time to first decision for reviewed
manuscripts is now 35 days and improving, with currently
20% of submitted manuscripts eventually being pub-
lished in the AJP. Time from acceptance to dissemination
will be shortened to a matter of a few weeks with our
implementation of website prepublication (fastPATH). For
a sneak peak of upcoming articles, I invite you to visit our
website now to preview the Tables of Contents for future
issues (fTOCs). Keep your eye on this section because
soon these fTOCs will include links to the prepublished
versions of articles. From this prepublished content, the
National Library of Medicine will be able to index ab-
stracts for earlier inclusion of your work in PubMed.
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The AJP is also pleased to announce its affiliation with
PubMed Central, by which content will be available not
only on our website but also on the PubMed Central
repository. As an added benefit to this affiliation, we are
now in a position to facilitate compliance with the en-
hanced public access rule that the National Institutes of
Health announced in May 2005. The AJP editorial office
will submit articles funded by the National Institutes of
Health directly to PubMed Central on behalf of our au-
thors, with instructions to make those articles freely avail-
able to the public six months after print publication. This
is the same point that the definitive version is publicly
accessible from the AJP website.
There are many other subtle and not so subtle ways
that we continue to better the AJP, both in content and
exposure. We continue to add new features to the web-
site, such as the lists of the 50 most-read and 50 most-
cited articles in the AJP, expanded announcements, di-
rect information about obtaining “permissions,” and other
requested information along with improved search and
indexing features. Additionally, the Instructions to Au-
thors have been fine tuned to include updated infor-
mation regarding submission requirements and fees,
confidentiality and copyright issues, and expanded
descriptions of author- and reviewer-related standards
of conduct.
The American Society for Investigative Pathology will
begin offering a certified continuing medical education
program, incorporating content from the AJP. Dr. Mark
Sobel has outlined this effort in a special notice to read-
ers, below.
I hope you agree that we continue to improve the
quality of the AJP by developing better content for our
readers and expanding the services that we offer our
authors, reviewers, and editorial board members. As I
said above, scientific publishing is a dynamic relation-
ship and reflects the sharing of ideas and aims that are
central to each of our pursuits of scientific discovery. The
things that drive you in your research and that drive you
to submit and read the AJP are the same things that drive
us. Therefore, we will be instituting a series of surveys
asking readers and authors to grade our performance
and tell us what you would put on your wishlist for the
AJP’s future. I invite you to actively participate and look
forward to your responses. At any time, I welcome your
thoughts on how we can make the AJP better still.
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Message from Mark Sobel, M.D., Ph.D., Executive
Officer of the American Society for Investigative
Pathology
To further enhance the visibility of journal articles and
as a service to the pathology community, the American
Society for Investigative Pathology (ASIP) is launching
two continuing medical education (CME) programs
based on articles published in The American Journal of
Pathology, entitled “ASIP Journal CME Program in Patho-
genesis,” and in The Journal of Molecular Diagnostics, en-
titled “JMD CME Program in Molecular Diagnostics.” The
goal of the ASIP Journal CME Program in Pathogenesis,
which is accredited for 50 CME credits, is to highlight the
latest advances in cell and molecular biology of dis-
eases, the mechanisms underlying basic physiological
processes, and how these pathways and mechanisms
contribute to pathology and disease. Participants will
answer questions regarding overall scientific conclusions
and experimental methodology of selected articles of The
American Journal of Pathology. See the back of this issue
for the first set of CME questions based on this month’s
content.
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